Literature DB >> 4106805

An eosinophil leukocyte chemotactic factor of anaphylaxis.

A B Kay, D J Stechschulte, K F Austen.   

Abstract

The capacity of actively or passively sensitized guinea pig lung to react with antigen to release a factor specifically chemotactic for eosinophil leukocytes (ECF-A) has been demonstrated. The release of ECF-A was also accompanied by the elaboration of both histamine and SRS-A and the appearance of all these mediators exhibited a similar response in terms of the time course of passve sensitization, the effect of antigen dose, the time course of release, divalent cation dependence and enhancement by the presence of succinate or maleate. Decomplementation by the administration of purified cobra venom factor had no effect on the antigen-induced release of ECF-A from actively or passively sensitized lung fragments. When fragments of guinea pig lung were passively sensitized with fractions of guinea pig 7S IgG, only the IgG(1)-containing fractions prepared tissue for the antigen-induced release of ECF-A. Histamine, SRS-A, bradykinin, serotonin, and the prostaglandins PGE(1), PGE(2), and PGF(2alpha) were not eosinophilotactic per se; neither was ECF-A detected following the incubation of these agents with sensitized lung in the absence of antigen. Both eosinophilotactic activity and SRS-A survived extraction in 80% ethanol and evaporation to dryness. SRS-A, however, withstood boiling in alkaline solution for 20 min, whereas ECF-A activity was abolished by this procedure. SRS-A and ECF-A could also be separated by gel filtration. ECF-A activity was completely recovered following its passage through a column of Sephadex G-25 and had an estimated molecular weight of between 500 and 1000. On the basis of size and a formation mechanism independent of the complement system, ECF-A is distinguishable from a previously described complement-dependent eosinophilotactic factor (ECF-C). Thus, ECF-A represents a hitherto undescribed agent which selectively attracts eosinophil leukocytes.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106805      PMCID: PMC2138951          DOI: 10.1084/jem.133.3.602

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock.

Authors:  W E BROCKLEHURST
Journal:  J Physiol       Date:  1960-06       Impact factor: 5.182

2.  Inhibition of the anaphylactic reaction.

Authors:  J L MONGAR; H O SCHILD
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

Review 3.  Slow reacting substance of anaphylaxis.

Authors:  R P Orange; K F Austen
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

Review 4.  A molecular concept of immune cytolysis.

Authors:  H J Muller-Eberhard; U R Nilsson; A P Dalmasso; M J Polley; M A Calcott
Journal:  Arch Pathol       Date:  1966-09

5.  Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

6.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

7.  Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies.

Authors:  B BENACERRAF; Z OVARY; K J BLOCH; E C FRANKLIN
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

8.  Anaphylaxis in chopped guinea pig lung. II. Enhancement of the anaphylactic release of histamine and slow reacting substance by certain dibasic aliphatic acids and inhibition by monobasic fatty acids.

Authors:  K F AUSTEN; W E BROCKLEHURST
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

9.  Immunological specificity of delayed and immediate hypersensitivity reactions.

Authors:  B BENACERRAF; B B LEVINE
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

10.  Properties of guinea pig 7S antibodies. III. Identification of antibodies involved in complement fixation and hemolysis.

Authors:  K J BLOCH; F M KOURILSKY; Z OVARY; B BENACERRAF
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  53 in total

1.  The mediation of tissue eosinophilia in hypersensitivity reaction. I. Isolation of two different chemotactic factors from DNP-Ascaris extract-induced skin lesion in guinea-pig.

Authors:  M Hirashima; H Hayashi
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

2.  Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.

Authors:  A B Kay; J M McVie; A E Stuart; A Krajewski; L W Turnbull
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

3.  Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.

Authors:  A A Mahmoud; M K Stone; R W Kellermeyer
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Granulocytes (the red, white, and blue) in hypersensitivity reactions: A review.

Authors:  H F Dvorak; S Cohen; P A Ward
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

Review 5.  FPL 55712 -- an antagonist of slow reacting substance of anaphylaxis (SRS-A): a review.

Authors:  N Chand
Journal:  Agents Actions       Date:  1979-06

6.  Active cutaneous anaphylaxis in the guinea-pig. Immunological and inflammatory reactions.

Authors:  H K Muller; D L Healy
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

7.  Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, bradykinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig.

Authors:  J M Drazen; K F Austen
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

Review 8.  Mast cells in allergic diseases and mastocytosis.

Authors:  D L Marquardt; S I Wasserman
Journal:  West J Med       Date:  1982-09

9.  The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria.

Authors:  S I Wasserman; K F Austen; N A Soter
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

10.  Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes.

Authors:  B M Czarnetzki; W König; L M Lichtenstein
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.